Cargando…
Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysis
BACKGROUND: Glutaric aciduria type I (GA-I) is a rare metabolic disorder caused by inherited deficiency of glutaryl-CoA dehydrogenase. Despite high prognostic relevance of early diagnosis and start of metabolic treatment as well as an additional cost saving potential later in life, only a limited nu...
Autores principales: | Pfeil, Johannes, Listl, Stefan, Hoffmann, Georg F, Kölker, Stefan, Lindner, Martin, Burgard, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015693/ https://www.ncbi.nlm.nih.gov/pubmed/24135440 http://dx.doi.org/10.1186/1750-1172-8-167 |
Ejemplares similares
-
Impact of newborn screening and quality of therapy on the neurological outcome in glutaric aciduria type 1: a meta-analysis
por: Boy, Nikolas, et al.
Publicado: (2020) -
A cross-sectional controlled developmental study of neuropsychological functions in patients with glutaric aciduria type I
por: Boy, Nikolas, et al.
Publicado: (2015) -
Diagnosis and management of glutaric aciduria type I – revised recommendations
por: Kölker, Stefan, et al.
Publicado: (2011) -
Machine Learning Methods Improve Specificity in Newborn Screening for Isovaleric Aciduria
por: Zaunseder, Elaine, et al.
Publicado: (2023) -
Glutaric Aciduria Type I Missed by Newborn Screening: Report of Four Cases from Three Families
por: Spenger, Johannes, et al.
Publicado: (2021)